| CAS ID: | 65646-68-6 |
| Molecular Formula: | C26H33NO2 |
| Molecular Weight: | 391.6 g/mol |
| Monoisotopic Mass: | 391.2511 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | MCN-R-1967 | 4-HPR | FENRETINIDE |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C26H33NO2/c1-19(11-16-24-21(3)10-7-17-26(24,4)5)8-6-9-20(2)18-25(29)27-22-12-14-23(28)15-13-22/h6,8-9,11-16,18,28H,7,10,17H2,1-5H3,(H,27,29)/b9-6+,16-11+,19-8+,20-18+ | See All |
| InChI Key: | AKJHMTWEGVYYSE-FXILSDISSA-N | |
| Smiles: | C\C(=C/C=C/C(=C/C(=O)Nc1ccc(O)cc1)/C)\C=C\C2=C(C)CCCC2(C)C | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT02141958 | Disease | Cystic fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | May 20, 2014 | Last Verified | July 12, 2016 |
| Sponsor | Elias Matouk | ||
Trial Record 2
| ClinicalTrial ID | NCT03265288 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Recruiting |
| First Received | August 29, 2017 | Last Verified | February 8, 2019 |
| Sponsor | Laurent Pharmaceuticals Inc. | ||
| PubChem: | 5288209 |
| ChEMBL: | CHEMBL7301 |